MedPath

Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial

Not Applicable
Recruiting
Conditions
Degenerative Mitral Valve Disease
Mitral Regurgitation
Mitral Insufficiency
Functional Mitral Regurgitation
Interventions
Device: Edwards PASCAL System
Device: Abbott Mitraclip System
Registration Number
NCT03706833
Lead Sponsor
Edwards Lifesciences
Brief Summary

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team, and in patients with functional mitral regurgitation (FMR) on guideline directed medical therapy (GDMT)

Detailed Description

A prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter mitral valve repair with the Edwards PASCAL Transcatheter Valve Repair System compared to Abbott MitraClip in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team, and in patients with functional mitral regurgitation (FMR) on guideline directed medical therapy (GDMT)

Patients will be seen for follow-up visits at discharge, 30 days, 6 months, and annually through 5 years.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1247
Inclusion Criteria
  • Eighteen (18) years of age or older
  • Patient is able and willing to give informed consent and follow protocol procedures, and comply with follow-up visit requirements.
  • Patient is determined to be at prohibitive risk for mitral valve surgery by the heart team (CLASP IID cohort only).
  • Patient is on stable heart failure medications/Guideline Directed Medical Therapy (CLASP IIF cohort only)
  • Patient is determined to be a candidate for transcatheter mitral valve repair by the heart team for both PASCAL and MitraClip
  • Mitral regurgitation (3+ to 4+) by echo
  • Suitable valve and regurgitant jet morphology
  • Elevated corrected BNP > 400 pg/ml or corrected NT-pro BNP of > 900 pg/ml or heart failure hospitalization within the past 12 months (CLASP IIF cohort only)
  • LVEF ≥ 20% (and ≤ 50%; CLASP IIF cohort only)
Exclusion Criteria
  • Patient in whom a TEE is contraindicated or screening TEE is unsuccessful
  • Mitral valve anatomy which may preclude proper PASCAL or MitraClip access, use and/or deployment or sufficient reduction in mitral regurgitation
  • Patient with refractory heart failure requiring advanced intervention (i.e. left ventricular assist device, Status ≤5 heart transplantation) (ACC/AHA Stage D heart failure)
  • Clinically significant, untreated coronary artery disease
  • Recent stroke
  • Other severe valve disorders requiring intervention
  • Need for emergent or urgent surgery for any reason or any planned cardiac surgery within the next 12 months
  • Any prior mitral valve surgery or transcatheter mitral valve procedure (excluding chordal replacement or surgical annuloplasty repair)
  • Severe tricuspid regurgitation or tricuspid valve disease requiring surgery
  • Active rheumatic heart disease or rheumatic etiology for MR
  • Severe aortic stenosis or regurgitation
  • Known history of untreated, severe carotid stenosis
  • Recent deep vein thrombosis (DVT) or pulmonary embolism (PE)
  • Severe COPD
  • Pregnant or planning pregnancy within next 12 months. Note: Female patients of childbearing potential need to have a negative pregnancy test performed within 14 days prior to intervention and be adherent to an accepted method of contraception
  • Concurrent medical condition with a life expectancy of less than 12 months in the judgment of the Investigator
  • Patient is currently participating in another investigational biologic, drug or device clinical study where the primary study endpoint was not reached at time of enrollment
  • Other medical, social, or psychological conditions that preclude appropriate consent and follow-up, including patients under guardianship

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Edwards PASCAL System - CLASP IIDEdwards PASCAL SystemTranscatheter mitral valve repair with the Edwards PASCAL System in patients with degenerative mitral regurgitation
Edwards PASCAL System - CLASP IIFEdwards PASCAL SystemTranscatheter mitral valve repair with the Edwards PASCAL System in patients on guideline directed medical therapy with functional mitral regurgitation
Abbott Mitraclip System - CLASP IIDAbbott Mitraclip SystemTranscatheter mitral valve repair with the Abbott Mitraclip System in patients with degenerative mitral regurgitation
Abbott Mitraclip System - CLASP IIFAbbott Mitraclip SystemTranscatheter mitral valve repair with the Abbott Mitraclip System in patients on guideline directed medical therapy with functional mitral regurgitation
Edwards PASCAL System - Single-Arm RegistryEdwards PASCAL SystemTranscatheter mitral valve repair with the Edwards PASCAL System in patients with mitral regurgitation who were deemed non-randomizable by a central screening committee (CSC) due to complex anatomical features described in the current MitraClip Instructions for Use (IFU) but were considered suitable for the PASCAL system.
Primary Outcome Measures
NameTimeMethod
PASCAL is not inferior to Mitraclip with respect to the time to first heart failure hospitalization or death for the CLASP IIF Cohort only.From date of randomization until date of first heart failure hospitalization or death, through 5 year follow-up
PASCAL is not inferior to MitraClip with respect to the proportion of patients with major adverse events (MAE). The primary safety endpoint is a composite of Major Adverse Events (MAEs).30 days.
PASCAL is not inferior to Mitraclip with respect to the proportion of patients with MR severity reduction as measured by echocardiography using a scale of 0-4+ for the CLASP IID Cohort.6 months
Secondary Outcome Measures
NameTimeMethod
Functional Improvement (increase in 6 minute walk test in meters)30 days , 6 months, 1 year

Increase in 6 minute walk test in meters

Rates of various adverse events6 months; 12 months

Rates of various adverse events at 6 and 12 months

Functional improvement (quality of life) as assessed using the Kansas City Cardiomyopathy Questionnaire through 2 years30 days , 6 months, 1 year, 2 year

Number of points of improvement on a scale of 0-100 in Kansas City Cardiomyopathy Questionnaire, with higher scores associated with higher Quality of Life

Functional improvement (quality of life) as assessed by number of points of improvement on the Short Form Health Survey (EQ-5D-5L) questionnaire through30 days, 6 months, 1 year, 2 year

Number of points of improvement on a scale of 1-100 in Short Form Health Survey (EQ-5D-5L) questionnaire, with higher totals associated with higher Quality of Life

Functional improvement (quality of life) as assessed by number of points of improvement on the Short Form Health Survey (SF-36) questionnaire through 2 years30 days, 6 months, 1 year, 2 year

Number of points of improvement on a scale of 0-100 in Short Form Health Survey (SF-36) questionnaire, with higher totals associated with higher Quality of Life

Trial Locations

Locations (103)

Los Robles Hospital and Medical Center

🇺🇸

Thousand Oaks, California, United States

University of Colorado Hospital

🇺🇸

Aurora, Colorado, United States

Medical Center of the Rockies

🇺🇸

Loveland, Colorado, United States

Medstar Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

The Cardiac and Vascular Institute Research Foundation

🇺🇸

Gainesville, Florida, United States

Mount Sinai

🇺🇸

Miami Beach, Florida, United States

NCH Healthcare System Naples

🇺🇸

Naples, Florida, United States

AdventHealth Orlando

🇺🇸

Orlando, Florida, United States

Cleveland Clinic Florida

🇺🇸

Weston, Florida, United States

Piedmont Healthcare

🇺🇸

Atlanta, Georgia, United States

The University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

Banner University Medical Center

🇺🇸

Phoenix, Arizona, United States

Abrazo Arizona Heart Hospital

🇺🇸

Phoenix, Arizona, United States

Arizona Cardiovascular Research Center

🇺🇸

Phoenix, Arizona, United States

TMC Healthcare

🇺🇸

Tucson, Arizona, United States

Scripps Memorial Hospital La Jolla

🇺🇸

La Jolla, California, United States

PIH Health Good Samaritan Hospital

🇺🇸

Los Angeles, California, United States

Cedars Sinai Medical Center

🇺🇸

Los Angeles, California, United States

St. Joseph Hospital

🇺🇸

Orange, California, United States

UC Irvine

🇺🇸

Orange, California, United States

Sutter Medical Center-Sacramento

🇺🇸

Sacramento, California, United States

UC Davis Medical Center

🇺🇸

Sacramento, California, United States

Sutter Bay Area

🇺🇸

San Francisco, California, United States

Kaiser Permanente San Francisco

🇺🇸

San Francisco, California, United States

University of California, San Francisco

🇺🇸

San Francisco, California, United States

Stanford University

🇺🇸

Stanford, California, United States

Emory University Hospital and Emory University Hospital Midtown

🇺🇸

Atlanta, Georgia, United States

Northwestern University

🇺🇸

Chicago, Illinois, United States

Rush University Medical Center

🇺🇸

Chicago, Illinois, United States

Advocate Health & Hospitals Corp/Edward Heart Hospital

🇺🇸

Naperville, Illinois, United States

St. Vincent Heart Center

🇺🇸

Carmel, Indiana, United States

University of Iowa Hospitals & Clinics

🇺🇸

Iowa City, Iowa, United States

Cardiovascular Research Institute of Kansas

🇺🇸

Wichita, Kansas, United States

Ochsner Medical Center

🇺🇸

New Orleans, Louisiana, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Brigham and Woman's Hospital

🇺🇸

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

🇺🇸

Boston, Massachusetts, United States

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

Fairview Health Services

🇺🇸

Maplewood, Minnesota, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

CentraCare Heart and Vascular Center

🇺🇸

Saint Cloud, Minnesota, United States

St.Luke's Hospital of Kansas City

🇺🇸

Kansas City, Missouri, United States

Washington University/Barnes Jewish Hospital

🇺🇸

Saint Louis, Missouri, United States

Morristown Medical Center

🇺🇸

Morristown, New Jersey, United States

Rutgers-RWJMS

🇺🇸

New Brunswick, New Jersey, United States

Albany Medical College

🇺🇸

Albany, New York, United States

Montefiore Medical Center

🇺🇸

Bronx, New York, United States

State University of New York at Buffalo

🇺🇸

Buffalo, New York, United States

Lankenau Medical Center

🇺🇸

Wynnewood, Pennsylvania, United States

WellSpan York Hospital

🇺🇸

York, Pennsylvania, United States

Baptist Memorial Hospital Memphis

🇺🇸

Memphis, Tennessee, United States

Centennial Medical Center

🇺🇸

Nashville, Tennessee, United States

Saint Thomas Heart at Saint Thomas West

🇺🇸

Nashville, Tennessee, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

Medical City Dallas

🇺🇸

Dallas, Texas, United States

NYU Langone Hospital - Long Island

🇺🇸

Mineola, New York, United States

Lenox Hill Hospital and North Shore University

🇺🇸

New York, New York, United States

The Christ Hospital

🇺🇸

Cincinnati, Ohio, United States

Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

Hospital of the University of Pennsylvania/Penn Presbyterian Medical Center

🇺🇸

Philadelphia, Pennsylvania, United States

Pinnacle Health Cardiovascular Institute/ UPMC Pinnacle Harrisburg

🇺🇸

Wormleysburg, Pennsylvania, United States

NYU Langone Health

🇺🇸

New York, New York, United States

Rochester General Hospital

🇺🇸

Rochester, New York, United States

OhioHealth Research Institute

🇺🇸

Columbus, Ohio, United States

Integris Health Baptist Medical Center

🇺🇸

Oklahoma City, Oklahoma, United States

Oklahoma Cardiovascular

🇺🇸

Oklahoma City, Oklahoma, United States

Providence St. Vincent Medical Center

🇺🇸

Portland, Oregon, United States

Columbia University Medical Center/New York Presbyterian Hospital

🇺🇸

New York, New York, United States

The Ohio State University Medical Center

🇺🇸

Columbus, Ohio, United States

Oklahoma Heart Institute

🇺🇸

Tulsa, Oklahoma, United States

St. Francis Hospital

🇺🇸

Roslyn, New York, United States

Atrium Health/Sanger Heart & Vascular Institute

🇺🇸

Charlotte, North Carolina, United States

Oregon Health & Science University

🇺🇸

Portland, Oregon, United States

Allegheny General Hospital

🇺🇸

Pittsburgh, Pennsylvania, United States

HCA Houston Healthcare Medical Center

🇺🇸

Houston, Texas, United States

Baylor College of Medicine

🇺🇸

Houston, Texas, United States

Houston Methodist Hospital

🇺🇸

Houston, Texas, United States

The University of Texas Health Science Center at Houston

🇺🇸

Houston, Texas, United States

The Heart Hospital Baylor Plano

🇺🇸

Plano, Texas, United States

Intermountain Medical Center

🇺🇸

Salt Lake City, Utah, United States

University of Virginia

🇺🇸

Charlottesville, Virginia, United States

Sentara Norfolk General Hospital

🇺🇸

Norfolk, Virginia, United States

Chippenham Johnston & Willis Medical Center

🇺🇸

Richmond, Virginia, United States

Swedish Medical Center

🇺🇸

Seattle, Washington, United States

University of Washington

🇺🇸

Seattle, Washington, United States

Aurora St. Luke's Medical Center

🇺🇸

Milwaukee, Wisconsin, United States

St. Pauls Hospital

🇨🇦

Vancouver, British Columbia, Canada

St. Michael's Hospital

🇨🇦

Toronto, Ontario, Canada

Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ) ULaval

🇨🇦

Québec, Canada

Klinik für Allgemeine und Interventionelle Kardiologie/Angiologie, Herz- und Diabeteszentrum NRW, Universitätsklinik der Ruhr-Universität Bochum

🇩🇪

Bad Oeynhausen, Germany

Herzzentrum Universitätsklinikum Koln

🇩🇪

Cologne, Germany

Herrzentrum Dresden GmbH Universitätklinik an der Technischen Universität Dresden

🇩🇪

Dresden, Germany

Universitätsklinikum Essen (AöR) Klinik für Kardiologie und Angiologie am Westdeutschen Herz- und Gefäßzentrum

🇩🇪

Essen, Germany

Universitätsklinikum Gießen Medizinische Klinik I, Innere Medizin/ Kardiologie

🇩🇪

Gießen, Germany

Universitäres Herzzentrum Hamburg GmbH (UHZ) Klinik und Poliklinik für Allgemeneine und Interventionelle Kardiologie

🇩🇪

Hamburg, Germany

Universitätsklinikum Heidelberg Klinik für Kardiologie, Angiologie, Pneumologie

🇩🇪

Heidelberg, Germany

Herzzentrum Leipzig Universitätsklinik für Kardiologie

🇩🇪

Leipzig, Germany

Zentrum für Kardiologie - Kardiologie I Universitätsmedizin der Johannes Gutenberg Universität Mainz

🇩🇪

Mainz, Germany

Medizinische Klinik I LMU München Campus Grosshadern

🇩🇪

München, Germany

Helios Klinikum Siegburg

🇩🇪

Siegburg, Germany

ULM University Zentrum für Innere Medizin Klinik für Innere Medizin II

🇩🇪

Ulm, Germany

University Hospital Bern

🇨🇭

Bern, Switzerland

© Copyright 2025. All Rights Reserved by MedPath